Home - Products - Others - Other Targets - Ademetionine

Ademetionine

CAS No. 17176-17-9

Ademetionine ( —— )

Catalog No. M19348 CAS No. 17176-17-9

S-ADENOSYL-L-METHIONINE (SAM) is a ubiquitous methyl donor involved in a wide variety of biological reactions, including those mediated by DNA and protein methyltransferases.

Purity : 98%

COA

Datasheet

HNMR

HPLC

MSDS

Handing Instructions

Size	Price / USD	Stock	Quantity
5MG	38	In Stock
100MG	Get Quote	In Stock
200MG	Get Quote	In Stock
500MG	Get Quote	In Stock
1G	Get Quote	In Stock

Group Booking Get Quotation Bulk Inquiry Add to Cart

Biological Information

Product Name

Ademetionine
Note

Research use only, not for human use.
Brief Description

S-ADENOSYL-L-METHIONINE (SAM) is a ubiquitous methyl donor involved in a wide variety of biological reactions, including those mediated by DNA and protein methyltransferases.
Description

S-ADENOSYL-L-METHIONINE (SAM) is a ubiquitous methyl donor involved in a wide variety of biological reactions, including those mediated by DNA and protein methyltransferases. SAM reportedly ameliorates depression, pain associated with osteoarthritis and fibromyalgia, and liver toxicity.
Synonyms

——
Pathway

Others
Target

Other Targets
Recptor

Others
Research Area

——
Indication

——

Chemical Information

CAS Number

17176-17-9
Formula Weight

398.44
Molecular Formula

C15H22N6O5S
Purity

98%
Solubility

——
SMILES

C[S+](CCC(N)C([O-])=O)C[C@H]1O[C@H]([C@H](O)[C@@H]1O)n1cnc2c(N)ncnc12
Chemical Name

——

Shipping & Storage Information

Storage

(-20℃)
Shipping

With Ice Pack
Stability

≥ 2 years

Reference

1. Loenen, W.A.M. S-Adenosylmethionine: Jack of all trades and master of everything Biochemical Society Transactions 34(2), 330-333 (2006).

Calculator

Molecular Weight Calculator

Dilution Calculator

Molarity Calculator

molnova catalog

related products

LNP023 hydrochloride

LNP023 hydrochloride is an orally bioavailable, highly potent and highly selective factor B inhibitor with an IC50 of 10 nM.
Vazegepant HCl

Vazegepant is the first intranasal gepant for the acute treatment of migraine and has announced a positive phase II/III study.
AT-56

AT56, a specific inhibitor of prostaglandin D2 synthase enzymatic activity, blunted adipogenic aldosterone effects.

Sign In Join Free